top of page

10.1146/annurev-pharmtox-051921- 085407

10.3389/fimmu.2021.658840

logo.png

Our mission is to provide pre-clinical stabilised lipoxin mimetics that can, because of shared mechanisms, serve as single interventions for the amelioration of multiple debilitating age related inflammatory diseases and enhance healthy longevity.

LipidEv's Lipoxin analogue / mimetics are now exclusively available globally from

For technical details contact

For related summaries of LipidEv's activities and products please see the open access reviews: 

Ⓒ

LipidEv Ltd 2026

bottom of page